Clinical Trials Browser

Phase EARLY_PHASE1 × Motor Activity × Ipilimumab × Clear all

NCT05358938 2026-02-06

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Phase EARLY_PHASE1 Active not recruiting

Melanoma, Motor Activity, Skin Neoplasms, Carcinoma, Merkel Cell